Cipla inches up as its arm completes acquisition of 100% equity stake in Actor Pharma
Cipla is currently trading at Rs. 1442.15, up by 3.10 points or 0.22% from its previous closing of Rs. 1439.05 on the BSE.
The scrip opened at Rs. 1445.05 and has touched a high and low of Rs. 1457.20 and Rs. 1440.65 respectively. So far 8220 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,457.20 on 08-Feb-2024 and a 52 week low of Rs. 852.00 on 22-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1457.20 and Rs. 1385.05 respectively. The current market cap of the company is Rs. 116183.07 crore.
The promoters holding in the company stood at 33.47%, while Institutions and Non-Institutions held 49.99% and 16.53% respectively.
Cipla’s wholly owned subsidiary -- Cipla Medpro South Africa has completed the acquisition of 100% equity stake in Actor Pharma, South Africa (Actor) as on February 7, 2024. Accordingly, Actor will now be a wholly owned step-down subsidiary of the Company
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
